6-Day Sell-Off Sends Healthpeak Properties Stock Down -8.3%
Healthpeak Properties (DOC) stock hit day 6 of a continuous streak of days with losses, with cumulative losses over this period amounting to a -8.3% return. The company has lost about $1.2 Bil in value over the last 6 days, with its current market capitalization at about $13 Bil. The stock remains 12.2% below its value at the end of 2024. This compares with year-to-date returns of 16.4% for the S&P 500.
Healthpeak Properties’ recent move reflected a broader slump, as the real estate sector’s ETF fell 1.63% this week. Despite topping Q3 earnings estimates, macro uncertainty and increased short interest weighed on investor sentiment, overshadowing solid fundamentals and a planned $1 billion asset monetization.
What is the point? Sustained weakness can be more than noise. It often signals shifting sentiment or deeper concerns. A multi-day losing streak may warn of further downside, or present an opportunity to buy if fundamentals are intact. Our take: There are several things to fear in DOC stock given its overall Weak operating performance and financial condition. Hence, despite its Moderate valuation, this makes the stock look Risky (see Buy or Sell DOC).
For quick background, DOC is a fully integrated REIT providing high-quality Life Science, Medical Office, and Senior Housing real estate investments and developments.
- Why Google and SpaceX Are Taking AI Infrastructure to Space
- Should You Buy ServiceNow Stock Despite Its High Valuation?
- What To Expect From Wells Fargo Stock In 2026?
- Procter & Gamble Stock vs. Colgate-Palmolive Stock
- Buy or Sell Broadcom Stock?
- Triggers That Could Ignite the Next Rally In Amazon.com Stock
Comparing DOC Stock Returns With The S&P 500
The following table summarizes the return for DOC stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | DOC | S&P 500 |
|---|---|---|
| 1D | -1.6% | -0.3% |
| 6D (Current Streak) | -8.3% | -0.0% |
| 1M (21D) | -4.1% | 1.9% |
| 3M (63D) | -5.7% | 5.1% |
| YTD 2025 | -12.2% | 16.4% |
| 2024 | 8.8% | 23.3% |
| 2023 | -16.4% | 24.2% |
| 2022 | -27.5% | -19.4% |
Take a look at what history tells you about whether past dips like this have been buying opportunities or traps: DOC Dip Buyer Analysis.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 53 S&P constituents with 3 days or more of consecutive gains and 104 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 8 | 52 |
| 4D | 22 | 14 |
| 5D | 20 | 6 |
| 6D | 0 | 22 |
| 7D or more | 3 | 10 |
| Total >=3 D | 53 | 104 |
Key Financials for Healthpeak Properties (DOC)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $2.2 Bil | $2.7 Bil |
| Operating Income | $433.9 Mil | $471.2 Mil |
| Net Income | $306.0 Mil | $243.1 Mil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ2 | 2025 FQ3 |
|---|---|---|
| Revenues | $694.3 Mil | $705.9 Mil |
| Operating Income | $131.5 Mil | $131.7 Mil |
| Net Income | $31.7 Mil | $-117.1 Mil |
The losing streak DOC stock is currently on doesn’t inspire much confidence among investors. In contrast, Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.